Megmazid 500mg Injection
Marketer
Ridhima Biocare
Salt Composition
Ceftazidime (500mg)
Overview Megmazid 500mg Injection
Cefazolin 500mg Injection is a bacterial infection treatment administered intravenously or intramuscularly. Effective against infections affecting the brain, lungs, ears, urinary tract, skin, soft tissues, bones, joints, blood, and heart, it also prevents surgical site infections. This antibiotic inhibits bacterial growth, alleviating symptoms and resolving the infection. Dosage and administration (IV infusion or IM injection) are determined by a physician, requiring regular, evenly-spaced doses as prescribed. Complete the entire course; premature cessation may cause relapse. Common side effects include rash and diarrhea; injection site redness or pain may occur temporarily. Report persistent or bothersome side effects. Prior use disclosure of antibiotic allergies, liver or kidney issues, and other medications is crucial. Pregnant or breastfeeding individuals require physician consultation before use.
Uses of Megmazid 500mg Injection
Infections caused by bacteria
Major Benefits of Megmazid 500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Megmazid 500mg Injection:
- Rash
- Allergic reaction
- Injection site reaction
- Diarrhea
How to use Megmazid 500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Megmazid 500mg Injection works:
The antibiotic injection, Megmazid 500mg, acts by disrupting bacterial cell wall synthesis, thereby eliminating the bacteria's protective barrier and causing their demise.
SAFETY ADVICE
AlcoholSAFE
Megmazid 500mg Injection use alongside alcohol consumption presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Megmazid 500mg is typically deemed safe for use in pregnant individuals. Preclinical trials using animal models have revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Megmazid 500mg is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to infants. However, extended use of Megmazid 500mg Injection should be avoided due to potential side effects like skin rashes and diarrhea.
DrivingUNSAFE
Administering Megmazid 500mg Injection might induce drowsiness, blurred vision, and dizziness. Driving is prohibited if these effects manifest.
KidneyCAUTION
The use of Megmazid 500mg Injection requires careful consideration in individuals with impaired kidney function. Dosage modification of Megmazid 500mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Administering Megmazid 500mg Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification for Megmazid 500mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Megmazid 500mg Injection :
Omit a Megmazid 500mg Injection dose? Seek medical advice.
Facts to Know About Megmazid 500mg Injection
| Label | Value |
|---|---|
| Chemical Category | Extended-spectrum cephalosporins (generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Action Class | Third-generation Cephalosporins |
3,018 People bought this recently